Alnylam Pharmaceuticals, Inc. (ALNY)
248.68
+1.17
(+0.47%)
USD |
NASDAQ |
Sep 11, 16:00
248.73
+0.05
(+0.02%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price to Book Value : 24.56 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 24.56 |
| September 10, 2026 | 24.44 |
| September 09, 2026 | 25.48 |
| September 08, 2026 | 25.69 |
| September 04, 2026 | 26.28 |
| September 03, 2026 | 26.12 |
| September 02, 2026 | 26.41 |
| September 01, 2026 | 24.31 |
| August 31, 2026 | 23.77 |
| August 28, 2026 | 23.42 |
| August 27, 2026 | 23.36 |
| August 26, 2026 | 23.60 |
| August 25, 2026 | 23.71 |
| August 24, 2026 | 23.31 |
| August 21, 2026 | 23.33 |
| August 20, 2026 | 22.65 |
| August 19, 2026 | 23.96 |
| August 18, 2026 | 22.58 |
| August 17, 2026 | 22.18 |
| August 14, 2026 | 22.58 |
| August 13, 2026 | 22.43 |
| August 12, 2026 | 22.12 |
| August 11, 2026 | 21.85 |
| August 10, 2026 | 21.43 |
| August 07, 2026 | 21.65 |
| Date | Value |
|---|---|
| August 06, 2026 | 21.34 |
| August 05, 2026 | 22.59 |
| August 04, 2026 | 21.63 |
| August 03, 2026 | 21.76 |
| July 31, 2026 | 20.30 |
| July 30, 2026 | 20.29 |
| July 29, 2026 | 28.31 |
| July 28, 2026 | 28.48 |
| July 27, 2026 | 27.50 |
| July 24, 2026 | 26.84 |
| July 23, 2026 | 26.54 |
| July 22, 2026 | 26.37 |
| July 21, 2026 | 26.80 |
| July 20, 2026 | 26.93 |
| July 17, 2026 | 26.42 |
| July 16, 2026 | 27.96 |
| July 15, 2026 | 27.57 |
| July 14, 2026 | 27.78 |
| July 13, 2026 | 28.45 |
| July 10, 2026 | 29.51 |
| July 09, 2026 | 30.89 |
| July 08, 2026 | 31.95 |
| July 07, 2026 | 31.76 |
| July 06, 2026 | 30.92 |
| July 02, 2026 | 30.89 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals, Inc. | 20.42 |
| BridgeBio Pharma, Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 2.548 |
| Vertex Pharmaceuticals, Inc. | 6.449 |
| Pfizer Inc. | 1.854 |
Price to Book Value Related Metrics
| PE Ratio | 41.99 |
| PS Ratio | 7.119 |
| Price to Free Cash Flow | 43.08 |
| Price | 248.68 |
| Earnings Yield | 2.38% |
| Market Cap | 33.26B |
| Operating PE Ratio | 34.21 |
| Normalized PE Ratio | 43.20 |